Article: Does vitamin B12 help prevent cardiovascular disease?(Literature Review & Commentary)

The Vitamin Intervention for Stroke Prevention (VISP) trial did not show efficacy of high-dose vitamin therapy (2.5 mg of folic acid, 25 mg of pyridoxine, and 400 mcg of vitamin B12 daily) as compared with low-dose vitamin therapy (20 mcg of folic acid, 200 mcg of vitamin B6, and 6 mcg of vitamin B12 daily) with respect to recurrent vascular events in patients with a history of a stroke.

In a new study, the data from the VISP trial were re-analyzed, after exclusion of patients with low and very high vitamin B12 levels at baseline ( <250 and>637 pmol/L, representing the 25th and 95th percentiles). Patients with very low vitamin B12 levels (

Comment: The results of this ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!